OmniCath

OmniCath®

Interventional cardiology A catheter used to remove obstructing atherosclerotic plaques from blood vessels. See Endarterectomy.
References in periodicals archive ?
Our OmniCath atherectomy device, which addresses a potential $500 million market, last week received the CE Mark for quality.
The company's products include 100-percent-silicone-based catheters, through its Cathlab subsidiary; the Evert-O-Cath, a toposcopic catheter for site-specific drug delivery and fluid removal; the OmniCath, an atherectomy catheter designed to remove atherosclerotic plaque from obstructed blood vessels throughout the body; and the OmniFilter, which is used to prevent blood clots from reaching various organs of the body.
The company's products include 100 percent-silicone catheters, through its Cathlab subsidiary; the Evert-O-Cath, a toposcopic catheter for site-specific drug delivery and fluid removal; the OmniCath, an atherectomy catheter designed to remove atherosclerotic plaque from obstructed blood vessels throughout the body; and the OrnniFilter, which is used to prevent blood clots from reaching various organs of the body.
We have seen significant interest from doctors and hospitals all over the world for our 100 percent silicone catheter product line and will continue to develop our guidewire micro filter and the expansion of our OmniCath Clinical Trials.
The company's products include 100 percent-silicone-based catheters, through its Cathlab subsidiary; the Evert-O-Cath(TM), a toposcopic catheter for site-specific drug delivery and fluid removal; the OmniCath, an atherectomy catheter designed to remove athersclerotic plaque from obstructed blood vessels throughout the body; and the OmniFilter, which is used to prevent blood clots from reaching various organs of the body.
The company's products include 100%-silicone-based catheters, through its Cathlab subsidiary; the Evert-O-Cath(TM), a toposcopic catheter for site-specific drug delivery and fluid removal; the OmniCath, an atherectomy catheter designed to remove athersclerotic plaque from obstructed blood vessels throughout the body; and the OmniFilter, which is used to prevent blood clots from reaching various organs of the body.
The company's products include: 100% silicone-based catheters, through its Cathlab subsidiary; the Evert-O-Cath(TM), a toposcopic catheter for site-specific drug delivery and fluid removal; the OmniCath, an atherectomy catheter designed to remove athersclerotic plaque from obstructed blood vessels throughout the body; the OmniStent(TM), which uses stent technology for angioplasty and atherectomy procedures; and the OmniFilter, which is used to prevent blood clots from reaching various organs of the body.
The company's products include: 100% silicone-based catheters, through its Cathlab subsidiary; the Evert-O-CathT, a toposcopic catheter for site-specific drug delivery and fluid removal; the OmniCath, an atherectomy catheter designed to remove athersclerotic plaque from obstructed blood vessels throughout the body; the OmniStentT, which uses stent technology for angioplasty and atherectomy procedures; and the OmniFilter, which is used to prevent blood clots from reaching various organs of the body.
the OmniCath is a cost-efficient, minimally invasive device for the removal of plaque from obstructed blood vessels, which helps return blood flow to normal levels.
The Advisors agreed to begin Phase ll clinical trials and expedite the approval process for American BioMed's OmniCath 510(k) in the U.
This sale represents an initial shipment of the peripheral OmniCath now available for sale in Europe.
Simultaneously, Guerbet placed an order for 60 of American BioMed's new model Omnicath for sale in Europe concurrent with Guerbet's European market launch of the OmniCath.